scholarly article | Q13442814 |
P819 | ADS bibcode | 2009PNAS..10617025Z |
P356 | DOI | 10.1073/PNAS.0909292106 |
P932 | PMC publication ID | 2761329 |
P698 | PubMed publication ID | 19805117 |
P5875 | ResearchGate publication ID | 26871295 |
P50 | author | Peter G. Schultz | Q899840 |
Costas A Lyssiotis | Q47451178 | ||
Haiyan Tao | Q59297958 | ||
Heiko Wurdak | Q89782444 | ||
P2093 | author name string | John Walker | |
Yan Wang | |||
Jie Li | |||
Feng Yan | |||
Xu Wu | |||
Loren Miraglia | |||
Shoutian Zhu | |||
Anthony Orth | |||
Anna Galkin | |||
Buu P Tu | |||
Fanxiang Sun | |||
P2860 | cites work | Transforming activity of receptor tyrosine kinase tyro3 is mediated, at least in part, by the PI3 kinase-signaling pathway | Q22011040 |
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability | Q24300451 | ||
Autophosphorylation activity and association with Src family kinase of Sky receptor tyrosine kinase | Q24306999 | ||
Reevaluation of the roles of protein S and gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3 | Q24321841 | ||
Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB. | Q24530573 | ||
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival | Q24546291 | ||
Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3 | Q28138331 | ||
A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes | Q28204096 | ||
Acidification prevents endothelial cell apoptosis by Axl activation | Q28205422 | ||
Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl | Q28277798 | ||
Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas | Q28278559 | ||
Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases | Q28298018 | ||
Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor | Q28509336 | ||
Gas6 and the Tyro 3 receptor tyrosine kinase subfamily regulate the phagocytic function of Sertoli cells | Q28509872 | ||
Tyro-3 family receptors are essential regulators of mammalian spermatogenesis | Q28585555 | ||
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases | Q28587024 | ||
Large-scale analysis of the human and mouse transcriptomes | Q29547360 | ||
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma | Q29614282 | ||
Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. | Q33352015 | ||
Complex variant 15;17 translocations in acute promyelocytic leukemia. A case report and review of three-way translocations | Q33646603 | ||
The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils | Q33775026 | ||
Immunobiology of the TAM receptors | Q33796991 | ||
Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. | Q33970751 | ||
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma | Q34086791 | ||
Metastatic melanoma: chemotherapy | Q34156931 | ||
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases | Q34319294 | ||
Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications | Q34393597 | ||
BRAF somatic mutations in malignant melanoma and melanocytic naevi | Q34506145 | ||
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. | Q34568270 | ||
Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. | Q34576544 | ||
Clonogenic assay of cells in vitro. | Q34615431 | ||
TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer | Q34794927 | ||
The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia | Q35146531 | ||
c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. | Q35186010 | ||
Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis | Q35787813 | ||
Melanocytes and the microphthalmia transcription factor network | Q35965847 | ||
Growth arrest-specific gene 6 expression in human breast cancer. | Q36510114 | ||
New insight into BRAF mutations in cancer | Q36701579 | ||
Melanocyte biology and skin pigmentation | Q36742011 | ||
Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene | Q36800542 | ||
How to make a melanoma: what do we know of the primary clonal events? | Q37114124 | ||
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells | Q39954044 | ||
AXL is a potential target for therapeutic intervention in breast cancer progression. | Q40002526 | ||
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. | Q40014237 | ||
Mer receptor tyrosine kinase signaling: prevention of apoptosis and alteration of cytoskeletal architecture without stimulation or proliferation | Q40740717 | ||
Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells | Q40806568 | ||
The first laminin G-type domain in the SHBG-like region of protein S contains residues essential for activation of the receptor tyrosine kinase sky. | Q40883711 | ||
Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. | Q40887733 | ||
Overexpression of the Sky receptor tyrosine kinase at the cell surface or in the cytoplasm results in ligand-independent activation. | Q41258260 | ||
Stimulation of sky receptor tyrosine kinase by the product of growth arrest-specific gene 6. | Q41293269 | ||
Mouse mammary tumors express elevated levels of RNA encoding the murine homology of SKY, a putative receptor tyrosine kinase | Q41358591 | ||
Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. | Q46021434 | ||
Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme | Q46825520 | ||
Structure, expression, and activity of Tyro 3, a neural adhesion-related receptor tyrosine kinase. | Q46943661 | ||
Tyro 3 receptor tyrosine kinase and its ligand, Gas6, stimulate the function of osteoclasts | Q48001321 | ||
Stimulation of Sky tyrosine phosphorylation by bovine protein S--domains involved in the receptor-ligand interaction. | Q50948456 | ||
A receptor tyrosine kinase, Sky, and its ligand Gas 6 are expressed in gonads and support primordial germ cell growth or survival in culture. | Q52198087 | ||
Synthesis and secretion of the anticoagulant protein S and coexpression of the Tyro3 receptor in human lung carcinoma cells | Q77953982 | ||
P433 | issue | 40 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 17025-17030 | |
P577 | publication date | 2009-09-23 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | A genomic screen identifies TYRO3 as a MITF regulator in melanoma | |
P478 | volume | 106 |
Q92642778 | Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma |
Q37818577 | Advances in melanoma senescence and potential clinical application. |
Q39203678 | Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas |
Q38600613 | Autophagy-Dependent Crosstalk between GILT and PAX-3 Influences Radiation Sensitivity of Human Melanoma Cells. |
Q37258717 | Biology of the TAM receptors |
Q34273700 | Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells |
Q47148669 | Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma |
Q36126272 | Genome-wide transcriptome analysis of human epidermal melanocytes |
Q39499581 | Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase. |
Q94503455 | Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma |
Q37727531 | Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma |
Q33882025 | Kaliziri extract upregulates tyrosinase, TRP-1, TRP-2 and MITF expression in murine B16 melanoma cells. |
Q92185487 | Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma |
Q37571700 | MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL. |
Q30539324 | MERTK receptor tyrosine kinase is a therapeutic target in melanoma. |
Q35187734 | MITF in melanoma: mechanisms behind its expression and activity. |
Q37955105 | Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands. |
Q39308771 | Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line. |
Q58758062 | MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression |
Q38417606 | Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation. |
Q34226634 | PRKX, TTBK2 and RSK4 expression causes Sunitinib resistance in kidney carcinoma- and melanoma-cell lines |
Q26865736 | Pathways and therapeutic targets in melanoma |
Q47927484 | Pathways from senescence to melanoma: focus on MITF sumoylation. |
Q37777015 | Pathways of oncogene-induced senescence in human melanocytic cells |
Q38904862 | Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration. |
Q35053505 | Phosphoproteomic screen identifies potential therapeutic targets in melanoma |
Q42137176 | Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients |
Q37841746 | Receptor tyrosine kinases and their activation in melanoma. |
Q39224402 | Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion |
Q47104368 | SOX10-MITF pathway activity in melanoma cells. |
Q34005547 | Sox proteins in melanocyte development and melanoma |
Q39160959 | TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy |
Q37636630 | TAM receptors Tyro3 and Mer as novel targets in colorectal cancer. |
Q91597649 | TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer |
Q53110840 | Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer. |
Q60926729 | The Emerging Role of TYRO3 as a Therapeutic Target in Cancer |
Q54298179 | The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. |
Q37946457 | The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. |
Q37301914 | The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma |
Q38698452 | Tyro3 carboxyl terminal region confers stability and contains the autophosphorylation sites |
Q47222376 | Tyro3-mediated phosphorylation of ACTN4 at tyrosines is FAK-dependent and decreases susceptibility to cleavage by m-Calpain |